Stay updated on Anti-KIR & Checkpoint Inhibitors in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Anti-KIR & Checkpoint Inhibitors in Solid Tumors Clinical Trial page.

Latest updates to the Anti-KIR & Checkpoint Inhibitors in Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.5%
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.2.SummaryDifference0.8%
- Check51 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check65 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about a clinical trial involving lirilumab and nivolumab, and the addition of a new revision number.SummaryDifference5%
- Check73 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check80 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
Stay in the know with updates to Anti-KIR & Checkpoint Inhibitors in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-KIR & Checkpoint Inhibitors in Solid Tumors Clinical Trial page.